Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Oracil-VK

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 40Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/11/2025 BIOTIKA a.s.
    Slovakia
    		 Biotika A.S. Slovenska Lupca SK R1-CEP 1997-043 - Rev 02 Phenoxymethylpenicillin potassium 2008-02-08 Valid Chemical 149
    29/11/2025 North China Pharmaceutical Huasheng Co Ltd
    China
    		 North China Pharmaceutical Co., LTD. Shijiazhuang CN R0-CEP 2006-019 - Rev 00 Phenoxymethylpenicillin potassium 2008-11-26 Withdrawn by EDQM Failure to CEP procedure Chemical 2013-11-04 149